Atlas Trials

TaTME Versus Open Intersphincteric Resection After Neoadjuvant Concurrent Chemoradiotherapy.

Clinical trial NCT01836926 · COMPLETED

Trial details

NCT number
NCT01836926
Sponsor
Osama Mohammad Ali ElDamshety
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2013-04-01
Primary completion
2019-07-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.